LENZ
LENZ TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
LENZ vs peer average
72/100
LENZ vs. peer average (B vs. C)
Grade spread
B 2 · C 5 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ABBV is the first available peer comparator.
AbbVie's Vuity is a direct presbyopia-product competitor identified in LENZ's [2025 Form 10-K](https://www.sec.gov/Archives/edgar/data/1815776/000181577626000011/lenz-20251231.htm) [#10-K-2026-03-24]. AbbVie's diversified company valuation is not a close LENZ comparable.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LENZ
LENZ Therapeutics
ABBV
AbbVie
Grade
B
C
Momentum
5
92
Value
57
60
Sentiment
67
35
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ABBV
LENZ / ABBV
Grade Position
Above peers
LENZ vs. peer average (B vs. C)
72/100
Momentum
5
ABBVValue
57
ABBVSentiment
67
LENZRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LENZ
ABBV is the first peer returned for this comparison set.